RESMED INC — Director's Dealing 2013

Feb 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-01-30

Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-30	ResMed Common Stock	M	400000	$23.095	Acquired	1020916	Direct
2013-01-30	ResMed Common Stock	S	400000	$46.977	Disposed	620916	Direct
2013-01-30	ResMed Common Stock	G	88430	—	Disposed	620916	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-30	ResMed Common Stock Options	$23.095	M	400000	Disposed	2013-11-10	ResMed Common Stock (400000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	0	Indirect
ResMed Common Stock	200000	Indirect

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F2: This transaction was executed in multiple trades at prices ranging from $46.75 to $47.53. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: Transaction represents a distribution from the Peter C. Farrell December 2011 Annuity Trust Dr. Farrell is not the Trustee of the Annuity Trust.